News | June 24, 2024
MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
This strategic decision will unlock significant value for our scientific and industrial products business
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Merck shared updates on the company’s oncology pipeline and focused R&D approach
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
EBITDA before special items falls 1.3 percent to € 4.41 billion
Subscribe To Our Newsletter & Stay Updated
